# A Comparative Study of an Innovative 3-lead Wireless Water Resistant Holter System and a Conventional Holter System

Study · id `cardio:ct-nct04723355` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04723355](<https://clinicaltrials.gov/study/NCT04723355>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04723355

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.

## Technical summary

Registry record NCT04723355. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-01-26 (actual); primary completion 2021-11-16 (actual). Results posted on 2024-10-24.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 231 participants (enrolled count; ClinicalTrials.gov record NCT04723355, source copy `cardio:ctgov-nct04723355-2024-10-24`, retrieved 2026-10-26)
- Started: 2021-01-26 (actual) (ClinicalTrials.gov record NCT04723355, source copy `cardio:ctgov-nct04723355-2024-10-24`, retrieved 2026-10-26)
- Primary completion: 2021-11-16 (actual) (ClinicalTrials.gov record NCT04723355, source copy `cardio:ctgov-nct04723355-2024-10-24`, retrieved 2026-10-26)
- Completion: 2021-11-16 (actual) (ClinicalTrials.gov record NCT04723355, source copy `cardio:ctgov-nct04723355-2024-10-24`, retrieved 2026-10-26)
- Results first posted: 2024-10-24 (ClinicalTrials.gov record NCT04723355, source copy `cardio:ctgov-nct04723355-2024-10-24`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT04723355, source copy `cardio:ctgov-nct04723355-2024-10-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04723355-2024-10-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Comparative Study of an Innovative 3-lead Wireless Water Resistant Holter System and a Conventional Holter System
- Condition: Cardiac Arrhythmia
- Intervention (Device): An innovative 3-lead wireless water resistant Holter device
- Intervention (Device): A conventional device
- Lead sponsor: Hospital Israelita Albert Einstein
- Lead sponsor class: OTHER
- Collaborator: Instituto Dante Pazzanese de Cardiologia
- Collaborator class: OTHER
- Collaborator: Quoretech
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Hospital Israelita Albert Einstein (`cardio:org-hospital-israelita-albert-einstein`)
- Registry lists this organization as a collaborator: Instituto Dante Pazzanese de Cardiologia (`cardio:org-instituto-dante-pazzanese-de-cardiologia`)

## Provenance

Content hash: ddfd4fa3b3704975059e9ab560eeb635a758d897e6234837eaee525d9bbb9983
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
